MaxCyte Inc
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland. Show More...
-
Website https://maxcyte.com
-
Sector Healthcare
-
Industry Medical Devices
-
Last Quote 168.00 GBX
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.09 -0.07 -0.09 -0.08 -0.11 -0.2 -0.17 -0.23 -0.23 Dividends USD Payout Ratio % * Shares Mil 43.0 43.0 43.0 43.0 34.0 49.0 51.0 56.0 56.0 Book Value Per Share * GBP 0.13 0.36 0.24 0.21 0.14 Free Cash Flow Per Share * GBP -0.04 -0.1 -0.18 -0.16 Return on Assets % -136.96 -106.91 -143.17 -55.39 -34.27 -41.78 -31.87 -47.54 -47.54 Financial Leverage (Average) 3.16 1.6 1.98 2.2 2.2 Return on Equity % -80.36 -55.64 -99.64 -99.64 Return on Invested Capital % -53.53 -40.15 -65.11 -65.11 Interest Coverage -31.23 -5.24 -2.27 -1.05 -4.25 -14.86 -13.43 -17.93 -17.93 Current Ratio 0.77 0.58 1.41 1.22 2.79 4.22 3.42 2.62 2.62 Quick Ratio 0.6 0.38 1.12 0.76 2.5 3.94 2.94 2.14 2.14 Debt/Equity 0.98 0.21 0.41 0.49 0.49